Safeguarding Women from Chemical Abortion Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Trade.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section ID164AFD34341A4B2C9F95D89E9BE7AF5C: 1. Short title This Act may be cited as the Safeguarding Women from Chemical Abortion Act.
- Section IDAA1B5BA81F9A49508FD4AE2711496CCC: 2. Withdrawal of approval of the drug mifepristone for termination of pregnancy Effective upon the expiration of 14 days after the date of the enactment of...
- Section id5edf29e874804d7290dfc569e4495e9e: 3. Federal tort for harm to women caused by chemical abortion drugs In this section: The term covered entity means a person that manufactures a covered...
- Section id66b7e98b36c1449c80e04e4afcfece90: 4. Rule of construction Nothing in this Act shall be construed to affect any provision of section 1461 of title 18, United States Code.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture, Trade
Primary Purpose
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Hawley introduced the following bill; which was read twice …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology